PROVECTUS BIOPHARMACEUTICALS, INC. Contracts & Agreements

2024 Financing Term Sheet (Filed With SEC on July 17, 2024)

Form of Unsecured Convertible Promissory Note (Filed With SEC on July 17, 2024)

Conversion Agreement, dated June 21, 2024, by and between the Company and Dominic Rodrigues (Filed With SEC on June 25, 2024)

Pershing Employment Agreement, dated April 16, 2024, between the Company and Ed Pershing (Filed With SEC on April 16, 2024)

Rodrigues Employment Agreement, dated April 16, 2024, between the Company and Dominic Rodrigues (Filed With SEC on April 16, 2024)

Description of Securities (Filed With SEC on March 28, 2024)

Exclusive License Agreement (with Equity), dated March 21, 2024, by and between the Company and University of Miami (Filed With SEC on March 27, 2024)

Independent Contractor and Director Fee Termination Agreement and Release, dated March 25, 2024, between the Company and Bruce Horowitz (Filed With SEC on March 26, 2024)

Independent Contractor Agreement, dated March 25, 2024, between the Company and Dominic Rodrigues (Filed With SEC on March 26, 2024)

Description of Securities (Filed With SEC on March 30, 2023)

2022 Financing Term Sheet (Filed With SEC on November 9, 2022)

Form of Unsecured Convertible Promissory Note (Filed With SEC on September 26, 2022)

Description of Securities (Filed With SEC on March 29, 2022)

2021 Financing Term Sheet (Filed With SEC on November 10, 2021)

Form of Unsecured Convertible Promissory Note (Filed With SEC on August 18, 2021)

Description of Securities (Filed With SEC on March 2, 2021)

Indemnification Agreement between the Company and Webster Bailey, effective as of July 20, 2020 (Filed With SEC on July 16, 2020)

2020 Definitive Financing Term Sheet (Filed With SEC on March 5, 2020)

Description of Securities (Filed With SEC on March 5, 2020)

Form of PRH 2 Secured Convertible Promissory Note (Filed With SEC on January 7, 2020)

Executive Employment Agreement between the Company and Eric A. Wachter, Ph.D., dated May 17, 2019 (Filed With SEC on May 20, 2019)

Amendment to the Independent Contractor Agreement dated April 19, 2017 between the Company and Bruce Horowitz, dated May 8, 2019 (Filed With SEC on May 9, 2019)

Employment Agreement between the Company and Heather Raines, dated March 25, 2019 (Filed With SEC on March 25, 2019)

Secured Convertible Promissory Note between the Company and Edward V. Pershing, dated July 26, 2018 (Filed With SEC on July 30, 2018)

Second Amendment to Amended and Restated Secured Convertible Promissory Note between the Company and Eric Wachter, Ph.D., dated January 22, 2018 (Filed With SEC on May 9, 2018)

Third Amendment to Amended and Restated Secured Convertible Promissory Note between the Company and Eric Wachter, Ph.D., dated January 22, 2018 (Filed With SEC on May 9, 2018)

Fourth Amendment to Amended and Restated Secured Convertible Promissory Note between the Company and Eric Wachter, Ph.D., dated January 22, 2018 (Filed With SEC on May 9, 2018)

First Amendment to Amended and Restated Secured Convertible Promissory Note between the Company and CAL Enterprises LLC, dated January 22, 2018 (Filed With SEC on May 9, 2018)

Indemnification Agreement between the Company and Ed Pershing, dated April 19, 2018 (Filed With SEC on April 24, 2018)

Indemnification Agreement between the Company and Jack Lacey, MD, dated April 19, 2018 (Filed With SEC on April 24, 2018)

Convertible Promissory Note between the Company and Timothy C. Scott, dated February 23, 2018 (Filed With SEC on February 26, 2018)

Secured Convertible Promissory Note between the Company and Eric A. Wachter, dated January 25, 2018 (Filed With SEC on January 30, 2018)

AMENDMENT NO. 1 TO THE INDEPENDENT CONTRACTOR AGREEMENT (Filed With SEC on August 9, 2017)

CONFIDENTIAL AMENDED AND RESTATEDDEFINITIVE FINANCING COMMITMENT TERM SHEET TO PROVECTUS BIOPHARMACEUTICALS,INC. DATED EFFECTIVE: March 19, 2017 (Filed With SEC on May 10, 2017)

INDEPENDENT CONTRACTOR AGREEMENT (Filed With SEC on April 20, 2017)

SECURED CONVERTIBLE PROMISSORY NOTE (this Note) (Filed With SEC on April 4, 2017)

AMENDED AND RESTATED SECURED CONVERTIBLE PROMISSORY NOTE (this Note) (Filed With SEC on April 4, 2017)

INDEMNIFICATION AGREEMENT (Filed With SEC on April 4, 2017)

AMENDMENT NO. 1 TO THE INDEPENDENT CONTRACTOR AGREEMENT (Filed With SEC on March 31, 2017)

CONVERTIBLE PROMISSORY NOTE (this Note) (Filed With SEC on February 21, 2017)

PROVECTUS BIOPHARMACEUTICALS, INC. DEALER-MANAGER AGREEMENT January 30, 2017 (Filed With SEC on February 3, 2017)

PROVECTUS BIOPHARMACEUTICALS, INC. DEALER-MANAGER AGREEMENT January , 2017 (Filed With SEC on January 26, 2017)

WARRANT AGENCY AGREEMENT (Filed With SEC on January 26, 2017)

PROVECTUS BIOPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on January 26, 2017)

FORM OF NON-TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE (Filed With SEC on January 19, 2017)

FORM OF NON-TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE (Filed With SEC on December 6, 2016)

FORM OF NON-TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE (Filed With SEC on November 1, 2016)

FORM OF NON-TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE (Filed With SEC on October 5, 2016)

WARRANT AGENCY AGREEMENT (Filed With SEC on August 30, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 25, 2016)

Form of Warrant PROVECTUS BIOPHARMACEUTICALS, INC. SERIES A WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 25, 2016)

EXCHANGE ANDESCROW AGENT AGREEMENT (Filed With SEC on May 13, 2016)

SECOND AMENDMENT TO WARRANT AGENCY AGREEMENT (Filed With SEC on May 13, 2016)

INDEPENDENT CONTRACTOR AGREEMENT (Filed With SEC on April 22, 2016)

EXCHANGE AND ESCROW AGENT AGREEMENT (Filed With SEC on December 31, 2015)

FIRST AMENDMENT TO WARRANT AGENCY AGREEMENT (Filed With SEC on December 31, 2015)

CONSENT AND WAIVER OF RIGHTS (Filed With SEC on June 24, 2015)

[FORM OF COMMON STOCK WARRANT CERTIFICATE] (Filed With SEC on June 19, 2015)

WARRANT AGENCY AGREEMENT (Filed With SEC on June 19, 2015)

17,500,000 SHARES OF COMMON STOCK AND 17,500,000WARRANTS OF PROVECTUS BIOPHARMACEUTICALS, INC. UNDERWRITING AGREEMENT (Filed With SEC on June 19, 2015)

IN THE CIRCUIT COURT FOR KNOX COUNTY, TENNESSEE (Filed With SEC on August 7, 2014)

PROVECTUS BIOPHARMACEUTICALS, INC. Up to $50,000,000 of Shares ofCommon Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on April 30, 2014)

AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on April 30, 2014)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 13, 2014)

PURCHASE AGREEMENT (Filed With SEC on July 26, 2013)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2013)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 28, 2013)

WARRANT (Filed With SEC on February 28, 2013)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 28, 2013)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2012)

WARRANT (Filed With SEC on April 20, 2011)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 16, 2011)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on January 13, 2011)

[FORMOF SERIES C WARRANT] PROVECTUSPHARMACEUTICALS, INC. WarrantTo Purchase Common Stock (Filed With SEC on January 13, 2011)

[FORMOF SERIES B WARRANT] PROVECTUSPHARMACEUTICALS, INC. WarrantTo Purchase Common Stock (Filed With SEC on January 13, 2011)

[FORMOF SERIES A WARRANT] PROVECTUSPHARMACEUTICALS, INC. WarrantTo Purchase Common Stock (Filed With SEC on January 13, 2011)

COMMONSTOCK PURCHASE WARRANT PROVECTUSPHARMACEUTICALS, INC. (Filed With SEC on December 23, 2010)

PURCHASEAGREEMENT (Filed With SEC on December 23, 2010)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on December 23, 2010)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on March 12, 2010)

WARRANT (Filed With SEC on March 12, 2010)

SECURITIES PURCHASEAGREEMENT (Filed With SEC on March 12, 2010)

Category

Industry

Companies

Contracts

PROVECTUS BIOPHARMACEUTICALS, INC. Contracts & Agreements